BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 13702952)

  • 1. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.
    GAINES S; LANDY M; EDSALL G; MANDEL AD; TRAPANI RJ; BENENSON AS
    J Exp Med; 1961 Sep; 114(3):327-42. PubMed ID: 13702952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines.
    TULLY JG; CURRIE JA
    J Bacteriol; 1962 Oct; 84(4):747-53. PubMed ID: 13994748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on chimpanzees on the efficacy of an oral typhoid immunization with an inactivated antigen].
    Engelhardt H
    Ann Sclavo; 1972; 14(5):626-31. PubMed ID: 4205299
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDIES ON INFECTION AND IMMUNITY IN EXPERIMENTAL TYPHOID FEVER. V. RESPIRATORY CHALLENGE OF CHIMPANZEES WITH SALMONELLA TYPHOSA.
    TULLY JG; GAINES S; TIGERTT WD
    J Infect Dis; 1963; 113():131-8. PubMed ID: 14064149
    [No Abstract]   [Full Text] [Related]  

  • 6. Attempts to induce typhoid fever in chimpanzees with non-VI strains of Salmonella typhosa.
    TULLY JG; GAINES S; TIGERTT WD
    J Infect Dis; 1962; 110():47-54. PubMed ID: 13923053
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody responses of man to three types of antityphoid immunizing agents: heat-phenol fluid vaccine, acetone-dehydrated vaccine, and isolated Vi and O antigens.
    LANDY M; GAINES S; SEAL JR; WHITSIDE JE
    Am J Public Health Nations Health; 1954 Dec; 44(12):1572-9. PubMed ID: 13207484
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statistical measurement of virulence and of immunity: application to the study of typhoid bacteria and to the measurement of immunizing power of antityphoid vaccines].
    BONET-MAURY P; JUDE A; SERVANT P
    Rev Immunol Ther Antimicrob; 1954; 18(1-2):21-49. PubMed ID: 13167818
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on incomplete antibodies during typhoid immunization. 1. On incomplete antibodies in the blood serum of typhoid bacilli immunized rabbits].
    MIZUTANI T
    Nihon Saikingaku Zasshi; 1961 May; 16():379-85. PubMed ID: 13771547
    [No Abstract]   [Full Text] [Related]  

  • 10. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
    Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
    Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Properdin level and antibody production in the rabbit during immunization with Mycobacterium tuberculosis and Salmonella typhosa].
    HEYMANN G; WAHLIG H
    Z Immun exp ther; 1959 Jul; 118():57-72. PubMed ID: 14401639
    [No Abstract]   [Full Text] [Related]  

  • 13. S. Typhi derived vaccines and a proposal for outer membrane vesicles (OMVs) as potential vaccine for typhoid fever.
    Haque S; Swami P; Khan A
    Microb Pathog; 2021 Sep; 158():105082. PubMed ID: 34265371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
    Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
    Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMMUNIZATION AGAINST TYPHOID AND PARATYPHOID FEVERS.
    ASHCROFT MT
    Clin Pediatr (Phila); 1964 Jul; 3():385-93. PubMed ID: 14192459
    [No Abstract]   [Full Text] [Related]  

  • 16. [The problem of control of anti-typhoid vaccines. V. The immunogenic value of antityphoid vaccines in relation to the antigenic structure of the strains used in their preparation].
    Gabbrielli G; Buzzanca E
    Boll Soc Ital Biol Sper; 1968 Apr; 44(8):725-8. PubMed ID: 5698500
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation of typhoid somatic-antigen vaccine. III. The rabbit intracutaneous challenge with Salmonella typhi in mucin.
    DIENA BB; WALLACE R; GREENBERG L
    Can J Microbiol; 1962 Feb; 8():35-41. PubMed ID: 13886263
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation of typhoid somatic-antigen vaccine. I. Biological studies of Salmonella typhi lysates.
    DIENA BB; WALLACE R; GREENBERG L
    Can J Microbiol; 1962 Feb; 8():19-26. PubMed ID: 13886261
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation of typhoid somatic-antigen vaccine. II. Serological studies of Salmonella typhi lysates.
    DIENA BB; WALLACE R; GREENBERG L
    Can J Microbiol; 1962 Feb; 8():27-33. PubMed ID: 13886262
    [No Abstract]   [Full Text] [Related]  

  • 20. [The importance of Vi- and O-antigens for formation of immunity to typhoid infections].
    Kolobova LF; Pershin BB
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):97-101. PubMed ID: 5511394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.